AVBP Latest Headlines

ArriVent’s MRG007 Phase I Trial Progress Adds Long-Term Option Value for AVBP Investors

at www.tipranks.com (Thu, 4-Jun 12:32 PM)

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)

at www.tipranks.com (Thu, 4-Jun 9:00 AM)

Analysts Offer Insights on Healthcare Companies: Vanda (VNDA), ArriVent BioPharma, Inc. (AVBP) and Medtronic (MDT)

at www.tipranks.com (Thu, 4-Jun 6:40 AM)

Guggenheim Remains a Buy on ArriVent BioPharma, Inc. (AVBP)

at www.tipranks.com (Mon, 1-Jun 1:55 PM)

B. Riley Securities Keeps Their Buy Rating on ArriVent BioPharma, Inc. (AVBP)

at www.tipranks.com (Mon, 1-Jun 9:27 AM)

Oppenheimer Keeps Their Buy Rating on ArriVent BioPharma, Inc. (AVBP)

at www.tipranks.com (Mon, 1-Jun 8:02 AM)